Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vatrano

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
European Heart Journal|February 6, 2026
Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-upStefano Ghio, Roberto Badagliacca, Michele D'Alto, et al.
ESC Heart Failure|February 19, 2026
Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-upLaura Scelsi, Roberto Badagliacca, Michele D'Alto, et al.
The European Respiratory Journal|March 18, 2022
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?Roberto Badagliacca, Silvia Papa, Michele D'Alto, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 11, 2026
ANMCO position paper E-health integration in cardiology clinical care frameworkFabiana Lucà, Gian Franco Gensini, Francesco Gabbrielli, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2026
[ANMCO Position paper: e-Health management in cardiovascular care pathways]Fabiana Lucà, Gian Franco Gensini, Francesco Gabbrielli, et al.
Vascular Pharmacology|March 1, 2026
2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspectiveGiovanna Manzi, Roberto Badagliacca, Michele D'Alto, et al.
Vascular Pharmacology|December 1, 2025
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk scoreSilvia Papa, Michele D'Alto, Laura Scelsi, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Heart Journal|February 6, 2026
Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-upStefano Ghio, Roberto Badagliacca, Michele D'Alto, et al.
ESC Heart Failure|February 19, 2026
Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-upLaura Scelsi, Roberto Badagliacca, Michele D'Alto, et al.
The European Respiratory Journal|March 18, 2022
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?Roberto Badagliacca, Silvia Papa, Michele D'Alto, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 11, 2026
ANMCO position paper E-health integration in cardiology clinical care frameworkFabiana Lucà, Gian Franco Gensini, Francesco Gabbrielli, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2026
[ANMCO Position paper: e-Health management in cardiovascular care pathways]Fabiana Lucà, Gian Franco Gensini, Francesco Gabbrielli, et al.
Vascular Pharmacology|March 1, 2026
2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspectiveGiovanna Manzi, Roberto Badagliacca, Michele D'Alto, et al.
Vascular Pharmacology|December 1, 2025
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk scoreSilvia Papa, Michele D'Alto, Laura Scelsi, et al.
Pageof 4